| Lastest Insider Transactions Of C4 Therapeutics, Inc. ( CCCC ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | 2026-02-13 | Option Exercise | 25,950 | 0.00 | 0 | 2026-02-18 17:05:18 |
| CCCC | C4 Therapeutics, Inc. | Mahaney Paige | Chief Scientific Officer | 2026-02-13 | Option Exercise | 7,050 | 0.00 | 0 | 2026-02-18 17:05:11 |
| CCCC | C4 Therapeutics, Inc. | Schick Kelly | Chief People Officer | 2026-02-13 | Option Exercise | 25,950 | 0.00 | 0 | 2026-02-18 17:05:05 |
| CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | President & CEO | 2026-02-13 | Option Exercise | 102,125 | 0.00 | 0 | 2026-02-18 17:04:58 |
| CCCC | C4 Therapeutics, Inc. | REYNO LEONARD | Chief Medical Officer | 2026-02-13 | Option Exercise | 30,950 | 0.00 | 0 | 2026-02-18 17:04:51 |
| CCCC | C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | 2026-02-13 | Option Exercise | 34,700 | 0.00 | 0 | 2026-02-18 17:04:45 |
| CCCC | C4 Therapeutics, Inc. | Mossler Mark | Chief Accounting Officer | 2026-02-13 | Option Exercise | 9,420 | 0.00 | 0 | 2026-02-18 17:04:38 |
| CCCC | C4 Therapeutics, Inc. | REYNO LEONARD | Chief Medical Officer | 2026-01-16 | Sell | 10,000 | 2.22 | 22,200 | 2026-01-16 16:27:58 |
| CCCC | C4 Therapeutics, Inc. | Mahaney Paige | Chief Scientific Officer | 2025-10-28 | Option Exercise | 19,200 | 0.00 | 0 | 2025-10-30 16:30:04 |
| CCCC | C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | 2025-09-18 | Option Exercise | 6,250 | 0.00 | 0 | 2025-09-19 16:13:49 |
| CCCC | C4 Therapeutics, Inc. | REYNO LEONARD | Chief Medical Officer | 2025-07-10 | Option Exercise | 15,325 | 0.00 | 0 | 2025-07-15 09:00:15 |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | 2025-02-13 | Sell | 1,159 | 3.15 | 3,651 | 2025-02-18 16:55:16 |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | 2024-11-07 | Option Exercise | 3,750 | 0.00 | 0 | 2024-11-12 16:17:43 |
| CCCC | C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | 2024-11-07 | Option Exercise | 3,750 | 0.00 | 0 | 2024-11-12 16:17:32 |
| CCCC | C4 Therapeutics, Inc. | Schick Kelly | Chief People Officer | 2024-11-07 | Option Exercise | 3,750 | 0.00 | 0 | 2024-11-12 16:17:22 |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | 2024-11-07 | Option Exercise | 3,750 | 0.00 | 0 | 2024-11-12 16:17:13 |
| CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | President & CEO | 2024-11-07 | Option Exercise | 12,500 | 0.00 | 0 | 2024-11-12 16:17:00 |
| CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | President & CEO | 2024-09-16 | Option Exercise | 7,500 | 0.00 | 0 | 2024-09-17 17:12:47 |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | 2024-09-16 | Option Exercise | 2,250 | 0.00 | 0 | 2024-09-17 17:12:36 |
| CCCC | C4 Therapeutics, Inc. | Adams Kendra | Chief Financial Officer | 2024-09-16 | Option Exercise | 2,250 | 0.00 | 0 | 2024-09-17 17:12:26 |
| CCCC | C4 Therapeutics, Inc. | Fisher Stewart | Chief Scientific Officer | 2024-09-16 | Option Exercise | 2,250 | 0.00 | 0 | 2024-09-17 17:12:16 |
| CCCC | C4 Therapeutics, Inc. | Schick Kelly | Chief People Officer | 2024-09-16 | Option Exercise | 2,250 | 0.00 | 0 | 2024-09-17 17:12:06 |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | 2024-09-16 | Option Exercise | 2,250 | 0.00 | 0 | 2024-09-17 17:11:56 |
| CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | President & CEO | 2023-08-30 | Option Exercise | 7,500 | 0.00 | 0 | 2023-08-31 16:13:51 |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | 2023-08-30 | Option Exercise | 2,250 | 0.00 | 0 | 2023-08-31 16:12:31 |
| CCCC | C4 Therapeutics, Inc. | White Lauren | Chief Financial Officer | 2023-08-30 | Option Exercise | 2,250 | 0.00 | 0 | 2023-08-31 16:11:31 |
| CCCC | C4 Therapeutics, Inc. | Schick Kelly | Chief People Officer | 2023-08-30 | Option Exercise | 2,250 | 0.00 | 0 | 2023-08-31 16:10:58 |
| CCCC | C4 Therapeutics, Inc. | Fisher Stewart | Chief Scientific Officer | 2023-08-30 | Option Exercise | 2,250 | 0.00 | 0 | 2023-08-31 16:10:27 |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | 2023-08-30 | Option Exercise | 2,250 | 0.00 | 0 | 2023-08-31 16:09:55 |
| CCCC | C4 Therapeutics, Inc. | Koppikar Utpal | Directior | 2023-02-08 | Buy | 5,667 | 5.60 | 31,735 | 2023-02-10 16:27:22 |
| CCCC | C4 Therapeutics, Inc. | Crystal Adam | Chief Medical Officer | 2023-01-30 | Option Exercise | 3,750 | 0.00 | 0 | 2023-02-01 16:11:13 |
| CCCC | C4 Therapeutics, Inc. | White Lauren | Chief Financial Officer | 2023-01-30 | Option Exercise | 3,750 | 0.00 | 0 | 2023-02-01 16:10:52 |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | 2023-01-30 | Option Exercise | 3,750 | 0.00 | 0 | 2023-02-01 16:10:28 |
| CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | President & CEO | 2023-01-30 | Option Exercise | 12,500 | 0.00 | 0 | 2023-02-01 16:09:52 |
| CCCC | C4 Therapeutics, Inc. | Schick Kelly | Chief People Officer | 2023-01-30 | Option Exercise | 3,750 | 0.00 | 0 | 2023-02-01 16:09:34 |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | 2023-01-30 | Option Exercise | 3,750 | 0.00 | 0 | 2023-02-01 16:09:12 |
| CCCC | C4 Therapeutics, Inc. | Fisher Stewart | Chief Scientific Officer | 2023-01-30 | Option Exercise | 3,750 | 0.00 | 0 | 2023-02-01 16:08:47 |
| CCCC | C4 Therapeutics, Inc. | Anderson Kenneth Carl | Directior | 2023-01-06 | Option Exercise | 712 | 3.90 | 2,777 | 2023-01-06 16:55:22 |
